Summary of Significant Accounting Policies - Other (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) customer segment	Dec. 31, 2021 USD ($)
Product Revenue, net
Number of customers | customer	1
Trade Receivables, net
Accounts receivable, net	$ 6,348	$ 2,629
Allowance for doubtful accounts.	$ 0	0
Payment terms	30 days
Number of customers | customer	1
Segment Information
Number of operating segments | segment	1
Accrued clinical trial expenses	$ 5,700
Prepaid clinical expenses	3,900
ZTALMY
Trade Receivables, net
Accounts receivable, net	1,300	$ 0
Inventory
Cost of product and materials included in research and development expenses prior to FDA approval	$ 2,000